Cargando…
Nuclear transport inhibition in acute myeloid leukemia: recent advances and future perspectives
Selective inhibitors of nuclear export (SINE) are emerging as a potentially efficacious therapeutic strategy for overcoming resistance to conventional chemotherapy for acute myeloid leukemia. SINE specifically block the protein Exportin 1, also known as chromosomal region maintenance 1, leading to n...
Autores principales: | Talati, Chetasi, Sweet, Kendra L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219429/ https://www.ncbi.nlm.nih.gov/pubmed/30405902 http://dx.doi.org/10.2217/ijh-2018-0001 |
Ejemplares similares
-
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia
por: Talati, Chetasi, et al.
Publicado: (2020) -
Molecular characteristics and outcomes in Hispanic and non‐Hispanic patients with acute myeloid leukemia
por: Bradley, Terrence, et al.
Publicado: (2022) -
Recent advances in the treatment of acute myeloid leukemia
por: Abdel-Wahab, Omar, et al.
Publicado: (2010) -
Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
por: Lv, Meng, et al.
Publicado: (2022) -
Recent advances in the understanding and treatment of acute myeloid leukemia
por: Watts, Justin, et al.
Publicado: (2018)